These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 15184256)
21. Effects of long term dietary phenethyl isothiocyanate on the microsomal metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in F344 rats. Staretz ME; Koenig LA; Hecht SS Carcinogenesis; 1997 Sep; 18(9):1715-22. PubMed ID: 9328166 [TBL] [Abstract][Full Text] [Related]
22. Metabolites of a tobacco-specific lung carcinogen in nonsmoking women exposed to environmental tobacco smoke. Anderson KE; Carmella SG; Ye M; Bliss RL; Le C; Murphy L; Hecht SS J Natl Cancer Inst; 2001 Mar; 93(5):378-81. PubMed ID: 11238699 [TBL] [Abstract][Full Text] [Related]
23. Metabolism of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone to its biomarker total NNAL in smokeless tobacco users. Hecht SS; Carmella SG; Stepanov I; Jensen J; Anderson A; Hatsukami DK Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):732-5. PubMed ID: 18349296 [TBL] [Abstract][Full Text] [Related]
24. One-Week Kava Dietary Supplementation Increases Both Urinary Hu Q; Tang Z; Lynch A; Freeman B; Fujioka N; Salloum RG; Malaty J; Orlando FA; Langaee T; Huo Z; Xing C Chem Res Toxicol; 2024 Sep; 37(9):1515-1523. PubMed ID: 39001862 [TBL] [Abstract][Full Text] [Related]
25. Correlation between the urine profile of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolites and N7-methylguanine in urothelial carcinoma patients. Lee HL; Hsueh YM; Chung CJ; Pu YS; Chang LW; Hsieh DP; Liou SH; Lin P Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3390-5. PubMed ID: 19064555 [TBL] [Abstract][Full Text] [Related]
26. Effects of dietary sinigrin or indole-3-carbinol on O6-methylguanine-DNA-transmethylase activity and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced DNA methylation and tumorigenicity in F344 rats. Morse MA; Wang CX; Amin SG; Hecht SS; Chung FL Carcinogenesis; 1988 Oct; 9(10):1891-5. PubMed ID: 3168166 [TBL] [Abstract][Full Text] [Related]
27. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mouse lung microsomes and its inhibition by isothiocyanates. Smith TJ; Guo ZY; Thomas PE; Chung FL; Morse MA; Elkind K; Yang CS Cancer Res; 1990 Nov; 50(21):6817-22. PubMed ID: 2208146 [TBL] [Abstract][Full Text] [Related]
28. Metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the patas monkey: pharmacokinetics and characterization of glucuronide metabolites. Hecht SS; Trushin N; Reid-Quinn CA; Burak ES; Jones AB; Southers JL; Gombar CT; Carmella SG; Anderson LM; Rice JM Carcinogenesis; 1993 Feb; 14(2):229-36. PubMed ID: 8435864 [TBL] [Abstract][Full Text] [Related]
30. Exposure to the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers from 3 populations with different risks of lung cancer. Derby KS; Cuthrell K; Caberto C; Carmella S; Murphy SE; Hecht SS; Le Marchand L Int J Cancer; 2009 Nov; 125(10):2418-24. PubMed ID: 19598261 [TBL] [Abstract][Full Text] [Related]
31. Chemoprevention of cancer by isothiocyanates, modifiers of carcinogen metabolism. Hecht SS J Nutr; 1999 Mar; 129(3):768S-774S. PubMed ID: 10082787 [TBL] [Abstract][Full Text] [Related]
32. Biomonitoring of environmental tobacco smoke (ETS)-related exposure to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Michael Meger Irmtrud Meger-Kossien Kirsten Riedel Gerhard Scherer Biomarkers; 2000; 5(1):33-45. PubMed ID: 23885904 [TBL] [Abstract][Full Text] [Related]
33. Metabolites of a tobacco-specific lung carcinogen in the urine of elementary school-aged children. Hecht SS; Ye M; Carmella SG; Fredrickson A; Adgate JL; Greaves IA; Church TR; Ryan AD; Mongin SJ; Sexton K Cancer Epidemiol Biomarkers Prev; 2001 Nov; 10(11):1109-16. PubMed ID: 11700257 [TBL] [Abstract][Full Text] [Related]
34. Clinical Trial of 2-Phenethyl Isothiocyanate as an Inhibitor of Metabolic Activation of a Tobacco-Specific Lung Carcinogen in Cigarette Smokers. Yuan JM; Stepanov I; Murphy SE; Wang R; Allen S; Jensen J; Strayer L; Adams-Haduch J; Upadhyaya P; Le C; Kurzer MS; Nelson HH; Yu MC; Hatsukami D; Hecht SS Cancer Prev Res (Phila); 2016 May; 9(5):396-405. PubMed ID: 26951845 [TBL] [Abstract][Full Text] [Related]
35. Association between Glucuronidation Genotypes and Urinary NNAL Metabolic Phenotypes in Smokers. Chen G; Luo S; Kozlovich S; Lazarus P Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1175-1184. PubMed ID: 27197298 [TBL] [Abstract][Full Text] [Related]
36. Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in smokers in the United States: NHANES 2007-2008. Xia Y; Bernert JT; Jain RB; Ashley DL; Pirkle JL Biomarkers; 2011 Mar; 16(2):112-9. PubMed ID: 21114376 [TBL] [Abstract][Full Text] [Related]
37. Chemoprevention by isothiocyanates. Hecht SS J Cell Biochem Suppl; 1995; 22():195-209. PubMed ID: 8538199 [TBL] [Abstract][Full Text] [Related]
38. Urinary levels of the tobacco-specific carcinogen N'-nitrosonornicotine and its glucuronide are strongly associated with esophageal cancer risk in smokers. Yuan JM; Knezevich AD; Wang R; Gao YT; Hecht SS; Stepanov I Carcinogenesis; 2011 Sep; 32(9):1366-71. PubMed ID: 21734256 [TBL] [Abstract][Full Text] [Related]
39. Determination of tobacco-specific N-nitrosamines in urine of smokers and non-smokers. Kavvadias D; Scherer G; Cheung F; Errington G; Shepperd J; McEwan M Biomarkers; 2009 Dec; 14(8):547-53. PubMed ID: 19747086 [TBL] [Abstract][Full Text] [Related]
40. Metabolites of a tobacco-specific lung carcinogen in nonsmoking casino patrons. Anderson KE; Kliris J; Murphy L; Carmella SG; Han S; Link C; Bliss RL; Puumala S; Murphy SE; Hecht SS Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1544-6. PubMed ID: 14693752 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]